The mission of Cure Alzheimer’s Fund is to fund research with the potential to accelerate a cure or disease-modifying treatment for Alzheimer’s disease. CureAlz seeks to identify and support investigators who will contribute to the field’s knowledge base with bold hypotheses and well-crafted experimental plans.

Current areas of investigation that Cure Alzheimer’s Fund will support include:

  1. Alzheimer’s Genome Project and Functional Genomics
  2. Genes to Therapies™/Stem Cell Drug Screening: Translational studies investigating established and newly confirmed AD genes
  3. Identification: Early detection via biomarkers, imaging, etc.
  4. Immune System Structures and Processes: Role of inflammation and other responses in Alzheimer’s
  5. Interaction of the Microbiome with Alzheimer’s
  6. Pathological Pathways & Systems
  7. Therapeutic Strategies and Drug Discovery
  8. Whole Genome Sequencing and Epigenetics
  9. Other: Novel approaches, targets, or therapies aligned with the Cure Alzheimer’s Fund mission


Cure Alzheimer’s Fund primarily supports invited proposals as referred by members of the Research Leadership Group (RLG). However, any qualified scientist may submit a one-page letter of inquiry to Cure Alzheimer’s Fund for review for fit with our scientific standards and research areas.

Letters of inquiry and proposals are accepted on a rolling basis; there is no set timeline for applications, funding decisions, or funding initiation.

Communications regarding Cure Alzheimer’s Fund applications and support should be sent to


The Research Leadership Group reviews each proposal for fit with the CureAlz research portfolio, scientific integrity, and value to the search for a cure for Alzheimer’s disease. The Executive Committee of the Board of Directors provides a final review to ensure all procedures have been followed and that the proposal fits within the organization’s mission to fund research contributing to a cure for Alzheimer’s disease.

Communications regarding Cure Alzheimer’s Fund applications and support should be sent to